LUNG CANCER RESEARCH FOUNDATION EXPANDS RESEARCH ADVOCATES
Volunteers provide patient and caregiver perspective to foundation's grant award process
NEW YORK, June 10, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) is pleased to announce the expansion of its Research Advocates. This select group of volunteers are patients, survivors, caregivers, healthcare professionals, and advocates committed to identifying and funding innovative lung cancer research.
This group plays a vital role in shaping LCRF's research priorities by helping to identify funding areas, draft requests for proposals (RFPs), review and provide feedback on grant applications, and support efforts in education, awareness, and fundraising.
'Patient involvement in LCRF's research grant process is a critical component to identifying areas of unmet need and helping to identify the most promising projects to fund,' remarked Dr. Antoinette Wozniak, LCRF's Chief Scientific Officer. 'With their lived experience and input, they ensure that we are investing in projects that have the greatest chance of making an impact on lung cancer and patient outcomes.'
'As a lung cancer survivor, I have experienced firsthand how vital research is—not just in developing new treatments, but in giving me hope for the future,' said Maggie McCloskey, a new LCRF Research Advocate. 'Advances in targeted therapies and immunotherapy have extended lives and improved quality of life for people like me. Research is not just about science—it is about creating more tomorrows for patients and their families. As a research advocate, I am proud to help bring that hope to others through research funded by the Lung Cancer Research Foundation.'
'I joined LCRF as a Patient Research Advocate because our voices are vital in shaping research that truly reflects the needs of patients. We are the ones living with the disease, and our experiences can drive more meaningful, patient-centered solutions that improve care and outcomes for everyone facing lung cancer,' remarked Sydney Barned, MD.
LCRF's Research Advocates:
New Members (2025)
Sydney Barned, MD – Annapolis, MD
Internal Medicine Physician & Hospitalist
Lung Cancer Patient/Survivor & Advocate
Terri Ann DiJulio – West Chester, PA
Lung Cancer Patient/Survivor & Advocate
Catherine Doliente – Houston, TX
Lung Cancer Patient/Survivor & Advocate
Deborah H. Friedman – Piermont, NY
Retired Publicist
Lung Cancer Survivor and Advocate
Stephanie Kaiser CRNP, AOCNP – Pittsburgh, PA
Thoracic Oncology and Hospice Nurse Practitioner, Board member, Libby's Lungs
Lung Cancer Patient/Survivor & Advocate
Matthew Koebbe – Madison, AL
IASLC Patient Research Advocate
Lung Cancer Patient/Survivor & Advocate
Maggie McCloskey – Moraga, CA
Lung Cancer Patient/Survivor & Advocate
Tillman Nechtman – Saratoga Springs, NY
Professor of History at Skidmore College
Former Caregiver
Tejal Patel, PharmD, MHA, BCPS – Chicago, IL
Vice President, Operations - Sinai Chicago
Lung Cancer Patient/Survivor & Advocate
Emily Walthall – Brevard, NC
RETpositive Board Co-Chair
Lung Cancer Patient/Survivor & Advocate
Existing Members:
Caroline Blanchard, DNP, FNP-C – Metairie, LA
Urologic Oncology Nurse Practitioner
Lung Cancer Patient/Survivor & Advocate
Colleen Conner Ziegler — Rochester, NY
LCRF Board of Directors, LCRF Scientific Executive Committee
Lung Cancer Patient/Survivor & Advocate
Denise Cutlip – Ypsilanti, MI
LCRF Education and Engagement Committee
Lung Cancer Patient/Survivor & Advocate
Dusty J. Donaldson — High Point, NC
Founder, Dusty Joy Foundation
Lung Cancer Patient/Survivor & Advocate
Bruce C. Dunbar — New Rochelle, NY
LCRF Board of Directors and Scientific Advisory Board member
Lung Cancer Patient/Survivor & Advocate
Stephen Huff – College Grove, TN
Founder of The Huff Project
Lung Cancer Patient/Survivor & Advocate
Tiffini Joseph, BSN, RN, CCRN – Pembroke Pines, FL
Pediatric CVICU, Joe DiMaggio Children's Hospital
Lung Cancer Patient Advocate
Kristen H. Kimball, MS, MEM — Boston, MA
Educator, UCONN
Lung Cancer Patient Advocate and Former Caregiver
Barbara LaMonaca — Falls Church, VA
BSN, Speech Pathology & Audiology, Retired
Lung Cancer Patient/Survivor & Advocate
Barbara Marsh, DSW, MSW – Miamisburg, OH
Social Worker
Caregiver/Lung Cancer Patient Advocate
Frank McKenna, MS Ed — Virginia Beach, VA
Cancer Exercise Specialist
Founder, Beach Better Bodies
Lung Cancer Patient/Survivor & Advocate
Aileen Murgatroyd – Yorkshire, UK
Lung Cancer Patient Advocate
Emily Venanzi, PhD — Newton, MA
ALK Positive Inc. Medical Committee
Lung Cancer Patient/Survivor & Advocate
Marc Tannenbaum, MD – New York, NY
Caregiver/Lung Cancer Patient Advocate
Randi Warren, MD – New York, NY
Lung Cancer Patient/Survivor & Advocate
About the Lung Cancer Research Foundation (LCRF)
The Lung Cancer Research Foundation® (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF's mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and cure of lung cancer. To date, LCRF has funded 429 research grants, totaling nearly $48 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. For more information, visit LCRF.org.
Contact:
Sheila Sullivan,
Sr. Director, Marketing & Communications
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/lung-cancer-research-foundation-expands-research-advocates-302477647.html
SOURCE Lung Cancer Research Foundation
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Wall Street Journal
27 minutes ago
- Wall Street Journal
Voyager Technologies Rises in Debut, Signaling Improving IPO Market
Shares of space and defense technology company Voyager Technologies surged in their New York Stock Exchange debut Wednesday, another sign of an improving market for initial public offerings. The stock ended the regular session at $56.48 and was up 6% after hours to $60.15.


New York Times
28 minutes ago
- New York Times
What Happens to Vaccines Now?
The U.S. health secretary's dismissal of an influential vaccine advisory committee this week sowed uncertainty about the future of vaccine recommendations nationwide. On Wednesday, Secretary Robert F. Kennedy Jr. announced eight new members of the Advisory Committee on Immunization Practices, which makes recommendations that are adopted by doctors, pharmacists, insurers and patients. His nominations included a physician who previously served on the committee, a scientist who has spread unfounded claims about Covid-19 vaccines and an epidemiologist who denounced Covid lockdowns. Mr. Kennedy's decision to overhaul the committee raised concerns among some medical experts, given his history of vaccine skepticism. For decades, ACIP has been a 'very important system to ensuring the health and safety of the country,' said Dr. Nancy Bennett, an emeritus professor of medicine and public health sciences at the University of Rochester School of Medicine and Dentistry and a former chair of the committee. 'It's hard to know what this huge disruption in the system will cause in the future,' Dr. Bennett said. How does the committee shape vaccine policy? Since 1964, ACIP has issued recommendations on the use of new and existing vaccines. ACIP usually meets three times a year, in discussions that are open to the public. The committee's voting members, who are medical experts with significant expertise in vaccines, virology and public health, are typically appointed by the health secretary for four-year terms. (The committee also has one consumer representative with an understanding of the social and community aspects of vaccination programs.) The group discusses and votes on key questions about vaccines, such as who should receive Covid boosters or at what ages children should receive certain shots. Want all of The Times? Subscribe.


Washington Post
37 minutes ago
- Washington Post
RFK Jr. picks new members of influential vaccine committee after purge
Health and Human Services Secretary Robert F. Kennedy Jr. named eight people to the influential federal panel that recommends vaccines to Americans days after he purged the entire membership of the group. His picks for the Advisory Committee on Immunization Practices include a well-known pediatric infectious diseases expert and at least two people who have criticized the use of mRNA coronavirus vaccines. Some of the more notable selections include Martin Kulldorff, the co-author of the Great Barrington Declaration, which called for herd immunity through mass covid infection in 2020, and Vicky Pebsworth, who has been listed on the board of the nation's oldest anti-vaccine group.